Structure

Physi-Chem Properties

Molecular Weight:  310.08
Volume:  314.438
LogP:  3.248
LogD:  2.706
LogS:  -4.296
# Rotatable Bonds:  4
TPSA:  65.74
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.548
Synthetic Accessibility Score:  2.025
Fsp3:  0.111
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.717
MDCK Permeability:  4.5673787099076435e-05
Pgp-inhibitor:  0.349
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.031
30% Bioavailability (F30%):  0.923

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.215
Plasma Protein Binding (PPB):  91.41058349609375%
Volume Distribution (VD):  0.581
Pgp-substrate:  5.637465000152588%

ADMET: Metabolism

CYP1A2-inhibitor:  0.926
CYP1A2-substrate:  0.658
CYP2C19-inhibitor:  0.608
CYP2C19-substrate:  0.064
CYP2C9-inhibitor:  0.574
CYP2C9-substrate:  0.919
CYP2D6-inhibitor:  0.552
CYP2D6-substrate:  0.899
CYP3A4-inhibitor:  0.48
CYP3A4-substrate:  0.289

ADMET: Excretion

Clearance (CL):  1.774
Half-life (T1/2):  0.29

ADMET: Toxicity

hERG Blockers:  0.091
Human Hepatotoxicity (H-HT):  0.049
Drug-inuced Liver Injury (DILI):  0.86
AMES Toxicity:  0.676
Rat Oral Acute Toxicity:  0.371
Maximum Recommended Daily Dose:  0.561
Skin Sensitization:  0.8
Carcinogencity:  0.642
Eye Corrosion:  0.004
Eye Irritation:  0.731
Respiratory Toxicity:  0.422

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC136095

Natural Product ID:  NPC136095
Common Name*:   7-O-Acetylformononetin
IUPAC Name:   [3-(4-methoxyphenyl)-4-oxochromen-7-yl] acetate
Synonyms:   7-O-Acetylformononetin
Standard InCHIKey:  GGGJVAAAUYBGSQ-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C18H14O5/c1-11(19)23-14-7-8-15-17(9-14)22-10-16(18(15)20)12-3-5-13(21-2)6-4-12/h3-10H,1-2H3
SMILES:  CC(=O)Oc1ccc2c(c1)occ(c1ccc(cc1)OC)c2=O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL463063
PubChem CID:   908827
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0002586] O-methylated isoflavonoids
          • [CHEMONTID:0002606] 4'-O-methylated isoflavonoids
            • [CHEMONTID:0002687] 4'-O-methylisoflavones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20912 Wisteria brachybotrys Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[2853205]
NPO20912 Wisteria brachybotrys Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT165 Cell Line HeLa Homo sapiens Inhibition = 40.2 % PMID[456296]
NPT80 Cell Line Raji Homo sapiens Activity = 100.0 % PMID[456296]
NPT80 Cell Line Raji Homo sapiens Activity > 80.0 % PMID[456296]
NPT80 Cell Line Raji Homo sapiens Activity = 80.0 % PMID[456296]
NPT2 Others Unspecified Activity = 0.0 % PMID[456296]
NPT2 Others Unspecified Activity = 100.0 % PMID[456296]
NPT2 Others Unspecified Activity = 95.2 % PMID[456296]
NPT2 Others Unspecified Activity = 15.2 % PMID[456296]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC136095 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.985 High Similarity NPC103001
0.9627 High Similarity NPC254741
0.9549 High Similarity NPC292998
0.9478 High Similarity NPC66705
0.9474 High Similarity NPC182428
0.9416 High Similarity NPC473209
0.9412 High Similarity NPC253616
0.9403 High Similarity NPC223354
0.9398 High Similarity NPC278556
0.9398 High Similarity NPC284424
0.9343 High Similarity NPC36414
0.9338 High Similarity NPC268081
0.9333 High Similarity NPC125269
0.9328 High Similarity NPC473655
0.9328 High Similarity NPC101294
0.9281 High Similarity NPC24075
0.9275 High Similarity NPC472515
0.9265 High Similarity NPC99854
0.9209 High Similarity NPC474037
0.9197 High Similarity NPC472516
0.9197 High Similarity NPC161196
0.9155 High Similarity NPC470322
0.9155 High Similarity NPC154217
0.9137 High Similarity NPC11566
0.913 High Similarity NPC116632
0.913 High Similarity NPC7013
0.913 High Similarity NPC303644
0.913 High Similarity NPC209560
0.913 High Similarity NPC162680
0.913 High Similarity NPC259685
0.913 High Similarity NPC228661
0.913 High Similarity NPC266597
0.913 High Similarity NPC250266
0.913 High Similarity NPC294409
0.913 High Similarity NPC38153
0.913 High Similarity NPC181124
0.911 High Similarity NPC186507
0.9097 High Similarity NPC88445
0.9097 High Similarity NPC164299
0.9091 High Similarity NPC218300
0.9091 High Similarity NPC282335
0.9085 High Similarity NPC471590
0.9085 High Similarity NPC171656
0.9085 High Similarity NPC179970
0.9085 High Similarity NPC1886
0.9085 High Similarity NPC469953
0.9085 High Similarity NPC196137
0.9078 High Similarity NPC202981
0.9078 High Similarity NPC36181
0.9071 High Similarity NPC470856
0.9071 High Similarity NPC171094
0.9071 High Similarity NPC472409
0.9065 High Similarity NPC90665
0.9065 High Similarity NPC55162
0.9065 High Similarity NPC279668
0.9065 High Similarity NPC278323
0.9065 High Similarity NPC17848
0.9065 High Similarity NPC309154
0.9065 High Similarity NPC188947
0.9065 High Similarity NPC124269
0.9065 High Similarity NPC280284
0.9065 High Similarity NPC99333
0.9065 High Similarity NPC12175
0.9058 High Similarity NPC231772
0.9058 High Similarity NPC47815
0.9058 High Similarity NPC61546
0.9058 High Similarity NPC29353
0.9058 High Similarity NPC124784
0.9058 High Similarity NPC234133
0.9058 High Similarity NPC194281
0.9058 High Similarity NPC473887
0.9058 High Similarity NPC72452
0.9058 High Similarity NPC127447
0.9034 High Similarity NPC191104
0.9034 High Similarity NPC474735
0.903 High Similarity NPC211120
0.9028 High Similarity NPC266743
0.9023 High Similarity NPC49852
0.9023 High Similarity NPC475496
0.9023 High Similarity NPC41721
0.9021 High Similarity NPC181388
0.9014 High Similarity NPC470216
0.9014 High Similarity NPC94794
0.9014 High Similarity NPC470296
0.9014 High Similarity NPC112791
0.9014 High Similarity NPC188632
0.9014 High Similarity NPC59522
0.9014 High Similarity NPC196459
0.9014 High Similarity NPC87609
0.9007 High Similarity NPC103362
0.9007 High Similarity NPC254010
0.9007 High Similarity NPC3188
0.9007 High Similarity NPC110969
0.9 High Similarity NPC78913
0.9 High Similarity NPC265871
0.9 High Similarity NPC274784
0.9 High Similarity NPC329203
0.9 High Similarity NPC262635
0.9 High Similarity NPC310135
0.9 High Similarity NPC225153
0.9 High Similarity NPC20709
0.9 High Similarity NPC150648
0.9 High Similarity NPC18260
0.9 High Similarity NPC295384
0.9 High Similarity NPC261234
0.9 High Similarity NPC222342
0.8993 High Similarity NPC275055
0.8993 High Similarity NPC157855
0.8993 High Similarity NPC290291
0.8993 High Similarity NPC188879
0.8986 High Similarity NPC234560
0.8986 High Similarity NPC46869
0.8986 High Similarity NPC39426
0.8986 High Similarity NPC474983
0.8973 High Similarity NPC290671
0.8966 High Similarity NPC474648
0.8966 High Similarity NPC19238
0.8963 High Similarity NPC228184
0.8958 High Similarity NPC237635
0.8958 High Similarity NPC97716
0.8958 High Similarity NPC140120
0.8958 High Similarity NPC104406
0.8958 High Similarity NPC74539
0.8958 High Similarity NPC180477
0.8958 High Similarity NPC79469
0.8958 High Similarity NPC304443
0.8958 High Similarity NPC201731
0.8958 High Similarity NPC24673
0.8955 High Similarity NPC473907
0.8951 High Similarity NPC469935
0.8951 High Similarity NPC234629
0.8951 High Similarity NPC178627
0.8951 High Similarity NPC294365
0.8951 High Similarity NPC184649
0.8951 High Similarity NPC303185
0.8951 High Similarity NPC311741
0.8944 High Similarity NPC226636
0.8944 High Similarity NPC147145
0.8944 High Similarity NPC11561
0.8944 High Similarity NPC51146
0.8944 High Similarity NPC166858
0.8944 High Similarity NPC313036
0.8936 High Similarity NPC6407
0.8936 High Similarity NPC204985
0.8936 High Similarity NPC261227
0.8936 High Similarity NPC215311
0.8936 High Similarity NPC172250
0.8936 High Similarity NPC159275
0.8936 High Similarity NPC129853
0.8936 High Similarity NPC213659
0.8936 High Similarity NPC172986
0.8936 High Similarity NPC76445
0.8936 High Similarity NPC48624
0.8936 High Similarity NPC259166
0.8936 High Similarity NPC270883
0.8936 High Similarity NPC110228
0.8936 High Similarity NPC150522
0.8936 High Similarity NPC101366
0.8936 High Similarity NPC144118
0.8936 High Similarity NPC80962
0.8936 High Similarity NPC281207
0.8936 High Similarity NPC269652
0.8936 High Similarity NPC326109
0.8936 High Similarity NPC188243
0.8936 High Similarity NPC241100
0.8936 High Similarity NPC284550
0.8936 High Similarity NPC219917
0.8929 High Similarity NPC118813
0.8929 High Similarity NPC329225
0.8929 High Similarity NPC201395
0.8929 High Similarity NPC276905
0.8929 High Similarity NPC147686
0.8929 High Similarity NPC472460
0.8921 High Similarity NPC240593
0.8921 High Similarity NPC13408
0.8921 High Similarity NPC87545
0.8921 High Similarity NPC235428
0.8913 High Similarity NPC172262
0.8905 High Similarity NPC229646
0.8904 High Similarity NPC474660
0.8904 High Similarity NPC295036
0.8897 High Similarity NPC183236
0.8897 High Similarity NPC168085
0.8897 High Similarity NPC266572
0.8897 High Similarity NPC208303
0.8897 High Similarity NPC6511
0.8897 High Similarity NPC161864
0.8889 High Similarity NPC153758
0.8889 High Similarity NPC57470
0.8889 High Similarity NPC299011
0.8889 High Similarity NPC473894
0.8889 High Similarity NPC473927
0.8881 High Similarity NPC175504
0.8881 High Similarity NPC164980
0.8881 High Similarity NPC17262
0.8881 High Similarity NPC91560
0.8881 High Similarity NPC113089
0.8881 High Similarity NPC68104
0.8881 High Similarity NPC257097
0.8881 High Similarity NPC169591

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC136095 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9481 High Similarity NPD2796 Approved
0.9014 High Similarity NPD6799 Approved
0.9 High Similarity NPD1243 Approved
0.8986 High Similarity NPD1510 Phase 2
0.8986 High Similarity NPD3748 Approved
0.8958 High Similarity NPD920 Approved
0.8944 High Similarity NPD643 Clinical (unspecified phase)
0.8929 High Similarity NPD1549 Phase 2
0.8857 High Similarity NPD1552 Clinical (unspecified phase)
0.8857 High Similarity NPD1550 Clinical (unspecified phase)
0.8851 High Similarity NPD7819 Suspended
0.8851 High Similarity NPD7096 Clinical (unspecified phase)
0.8844 High Similarity NPD7411 Suspended
0.8819 High Similarity NPD642 Clinical (unspecified phase)
0.8819 High Similarity NPD4378 Clinical (unspecified phase)
0.8784 High Similarity NPD6801 Discontinued
0.8776 High Similarity NPD6599 Discontinued
0.8696 High Similarity NPD1240 Approved
0.8676 High Similarity NPD6832 Phase 2
0.8675 High Similarity NPD7075 Discontinued
0.8671 High Similarity NPD3750 Approved
0.8667 High Similarity NPD3817 Phase 2
0.8571 High Similarity NPD1607 Approved
0.8562 High Similarity NPD7410 Clinical (unspecified phase)
0.8562 High Similarity NPD5401 Approved
0.8551 High Similarity NPD6859 Clinical (unspecified phase)
0.8521 High Similarity NPD1551 Phase 2
0.8497 Intermediate Similarity NPD919 Approved
0.8472 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8446 Intermediate Similarity NPD5403 Approved
0.8431 Intermediate Similarity NPD3749 Approved
0.8431 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8411 Intermediate Similarity NPD1934 Approved
0.8403 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.84 Intermediate Similarity NPD4380 Phase 2
0.8369 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.8367 Intermediate Similarity NPD1511 Approved
0.8366 Intermediate Similarity NPD7768 Phase 2
0.8355 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8321 Intermediate Similarity NPD3267 Approved
0.8321 Intermediate Similarity NPD3266 Approved
0.8301 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8298 Intermediate Similarity NPD4307 Phase 2
0.8296 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.8288 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8286 Intermediate Similarity NPD2313 Discontinued
0.8255 Intermediate Similarity NPD1512 Approved
0.8235 Intermediate Similarity NPD2801 Approved
0.8205 Intermediate Similarity NPD5494 Approved
0.8194 Intermediate Similarity NPD2799 Discontinued
0.8188 Intermediate Similarity NPD1203 Approved
0.8182 Intermediate Similarity NPD5402 Approved
0.8156 Intermediate Similarity NPD1296 Phase 2
0.8129 Intermediate Similarity NPD3882 Suspended
0.8129 Intermediate Similarity NPD1019 Discontinued
0.8112 Intermediate Similarity NPD1933 Approved
0.8102 Intermediate Similarity NPD9717 Approved
0.8079 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8069 Intermediate Similarity NPD4308 Phase 3
0.8041 Intermediate Similarity NPD4628 Phase 3
0.8028 Intermediate Similarity NPD3268 Approved
0.8014 Intermediate Similarity NPD2935 Discontinued
0.8013 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD3818 Discontinued
0.8 Intermediate Similarity NPD2798 Approved
0.7975 Intermediate Similarity NPD5953 Discontinued
0.7974 Intermediate Similarity NPD3226 Approved
0.7963 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7945 Intermediate Similarity NPD7033 Discontinued
0.7929 Intermediate Similarity NPD2797 Approved
0.7925 Intermediate Similarity NPD1247 Approved
0.7899 Intermediate Similarity NPD422 Phase 1
0.7888 Intermediate Similarity NPD6166 Phase 2
0.7888 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7883 Intermediate Similarity NPD17 Approved
0.7857 Intermediate Similarity NPD3225 Approved
0.7853 Intermediate Similarity NPD7286 Phase 2
0.7853 Intermediate Similarity NPD7054 Approved
0.7853 Intermediate Similarity NPD5844 Phase 1
0.7852 Intermediate Similarity NPD2800 Approved
0.7838 Intermediate Similarity NPD2344 Approved
0.7838 Intermediate Similarity NPD2346 Discontinued
0.7834 Intermediate Similarity NPD4288 Approved
0.7829 Intermediate Similarity NPD2533 Approved
0.7829 Intermediate Similarity NPD2532 Approved
0.7829 Intermediate Similarity NPD2534 Approved
0.7826 Intermediate Similarity NPD3926 Phase 2
0.7812 Intermediate Similarity NPD6959 Discontinued
0.7805 Intermediate Similarity NPD7074 Phase 3
0.7805 Intermediate Similarity NPD7472 Approved
0.7778 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD6232 Discontinued
0.7762 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7761 Intermediate Similarity NPD1241 Discontinued
0.7758 Intermediate Similarity NPD6797 Phase 2
0.7756 Intermediate Similarity NPD5889 Approved
0.7756 Intermediate Similarity NPD5890 Approved
0.7733 Intermediate Similarity NPD2654 Approved
0.773 Intermediate Similarity NPD7473 Discontinued
0.7714 Intermediate Similarity NPD1608 Approved
0.7714 Intermediate Similarity NPD3972 Approved
0.7711 Intermediate Similarity NPD6559 Discontinued
0.7711 Intermediate Similarity NPD7251 Discontinued
0.7665 Intermediate Similarity NPD7808 Phase 3
0.7665 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD1465 Phase 2
0.7655 Intermediate Similarity NPD411 Approved
0.7632 Intermediate Similarity NPD2309 Approved
0.7632 Intermediate Similarity NPD3887 Approved
0.7619 Intermediate Similarity NPD5124 Phase 1
0.7619 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD447 Suspended
0.7609 Intermediate Similarity NPD9545 Approved
0.7609 Intermediate Similarity NPD1548 Phase 1
0.76 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD2353 Approved
0.758 Intermediate Similarity NPD6585 Discontinued
0.7576 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD6651 Approved
0.7566 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD5535 Approved
0.7551 Intermediate Similarity NPD943 Approved
0.7546 Intermediate Similarity NPD6808 Phase 2
0.7545 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD6798 Discontinued
0.7518 Intermediate Similarity NPD1610 Phase 2
0.7517 Intermediate Similarity NPD4908 Phase 1
0.75 Intermediate Similarity NPD230 Phase 1
0.7484 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD1876 Approved
0.7483 Intermediate Similarity NPD1471 Phase 3
0.7467 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD9493 Approved
0.7443 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD6100 Approved
0.7417 Intermediate Similarity NPD6099 Approved
0.7415 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD3764 Approved
0.7405 Intermediate Similarity NPD7458 Discontinued
0.7403 Intermediate Similarity NPD2354 Approved
0.7399 Intermediate Similarity NPD4287 Approved
0.7394 Intermediate Similarity NPD5242 Approved
0.7386 Intermediate Similarity NPD1652 Phase 2
0.7383 Intermediate Similarity NPD6355 Discontinued
0.7378 Intermediate Similarity NPD7199 Phase 2
0.7375 Intermediate Similarity NPD6279 Approved
0.7375 Intermediate Similarity NPD6280 Approved
0.7357 Intermediate Similarity NPD1894 Discontinued
0.7333 Intermediate Similarity NPD7229 Phase 3
0.7325 Intermediate Similarity NPD6273 Approved
0.7315 Intermediate Similarity NPD3142 Approved
0.7315 Intermediate Similarity NPD3140 Approved
0.7308 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD6971 Discontinued
0.7296 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD9697 Approved
0.7289 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD6233 Phase 2
0.7246 Intermediate Similarity NPD2403 Approved
0.7232 Intermediate Similarity NPD4360 Phase 2
0.7232 Intermediate Similarity NPD4363 Phase 3
0.7229 Intermediate Similarity NPD5710 Approved
0.7229 Intermediate Similarity NPD5711 Approved
0.7226 Intermediate Similarity NPD7003 Approved
0.7215 Intermediate Similarity NPD2186 Approved
0.7205 Intermediate Similarity NPD6386 Approved
0.7205 Intermediate Similarity NPD6385 Approved
0.7193 Intermediate Similarity NPD6104 Discontinued
0.7192 Intermediate Similarity NPD1164 Approved
0.7191 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7191 Intermediate Similarity NPD4361 Phase 2
0.719 Intermediate Similarity NPD4476 Approved
0.719 Intermediate Similarity NPD4477 Approved
0.7178 Intermediate Similarity NPD5353 Approved
0.716 Intermediate Similarity NPD6844 Discontinued
0.716 Intermediate Similarity NPD3751 Discontinued
0.7153 Intermediate Similarity NPD1281 Approved
0.7152 Intermediate Similarity NPD4622 Approved
0.7152 Intermediate Similarity NPD4618 Approved
0.7152 Intermediate Similarity NPD4661 Approved
0.7152 Intermediate Similarity NPD4662 Approved
0.7143 Intermediate Similarity NPD9261 Approved
0.7134 Intermediate Similarity NPD7440 Discontinued
0.7133 Intermediate Similarity NPD8032 Phase 2
0.7133 Intermediate Similarity NPD1778 Approved
0.7119 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD3134 Approved
0.7107 Intermediate Similarity NPD5049 Phase 3
0.7103 Intermediate Similarity NPD1481 Phase 2
0.7099 Intermediate Similarity NPD2366 Approved
0.7089 Intermediate Similarity NPD7390 Discontinued
0.7086 Intermediate Similarity NPD2979 Phase 3
0.7086 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD1613 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data